U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2008
174
Substance Class Protein
Created
by admin
on Mon Mar 31 23:07:48 GMT 2025
Edited
by admin
on Mon Mar 31 23:07:48 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG2A
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
UMD07X179E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
certolizumab pegol [INN]
Preferred Name English
CERTOLIZUMAB PEGOL
DASH   EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
CERTOLIZUMAB PEGOL [EMA EPAR]
Common Name English
CERTOLIZUMAB PEGOL [USAN]
Common Name English
CERTOLIZUMAB PEGOL [PURPLE BOOK CDER]
Common Name English
CERTOLIZUMAB PEGOL [MART.]
Common Name English
IMMUNOGLOBULIN, ANTI-(HUMAN TUMOR NECROSIS FACTOR .ALPHA.) FAB' FRAGMENT (HUMAN-MOUSE MONOCLONAL CDP870 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CDP870 LIGHT CHAIN, PEGYLATED
Common Name English
CERTOLIZUMAB PEGOL [JAN]
Common Name English
PHA-738144
Code English
CDP 870
Code English
CERTOLIZUMAB PEGOL [HSDB]
Common Name English
CDP870
Code English
CERTOLIZUMAB PEGOL [MI]
Common Name English
CERTOLIZUMAB PEGOL [VANDF]
Common Name English
CDP-870
Code English
Certolizumab pegol [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-VATC QL04AB05
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
WHO-ATC L04AB05
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
EMA ASSESSMENT REPORTS CIMZIA (REFUSED: CROHN DISEASE)
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
NDF-RT N0000175610
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
EMA ASSESSMENT REPORTS CIMZIA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
Code System Code Type Description
LACTMED
Certolizumab Pegol
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
WIKIPEDIA
CERTOLIZUMAB PEGOL
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
SMS_ID
100000089458
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201831
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
INN
8448
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
CAS
428863-50-7
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
DRUG CENTRAL
4968
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
MESH
C468008
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
EVMPD
SUB25423
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
DRUG BANK
DB08904
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
USAN
PP-10
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
RXCUI
709271
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY RxNorm
DAILYMED
UMD07X179E
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
MERCK INDEX
m3272
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY Merck Index
FDA UNII
UMD07X179E
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
IUPHAR
6774
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
NCI_THESAURUS
C80972
Created by admin on Mon Mar 31 23:07:48 GMT 2025 , Edited by admin on Mon Mar 31 23:07:48 GMT 2025
PRIMARY
From To
1_22 1_96
1_145 1_201
1_221 2_214
2_23 2_88
2_134 2_194
Related Record Type Details
TUMOR NECROSIS FACTOR-.ALPHA. HUMAN (PLASMA DERIVED, SOLUBLE FORM)
TARGET -> INHIBITOR
Related Record Type Details
CERTOLIZUMAB PEGOL
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_227] SITE_SPECIFIC UNSPECIFIED SUBSTANCE
71ab9ef8
(not in database)
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966